Ad
related to: the fda s
Search results
Baby formula recall updates with warning of potentially fatal infection
Newsweek· 2 hours agoAn updated recall announcement shared by the U.S. Food and Drug Administration (FDA) is warning that...
Panel rejects psychedelic drug MDMA as a PTSD treatment in possible setback for advocates
seattlepi.com· 28 minutes agoA panel of advisers to the Food and Drug Administration voted 10-1 against the overall benefits of...
FDA panel to review psychedelic drug MDMA for first time By Reuters
Investing.com· 12 hours agoThe meeting by the agency's independent experts is the farthest that a drug based on MDMA, commonly...
FDA advisers consider MDMA therapy to treat PTSD - WSVN 7News | Miami News, Weather, Sports | Fort...
7 News Miami· 11 hours agoIt’s the first time the FDA’s advisers have considered a psychedelic drug for medical use. The novel...
‘Frances Oldham Kelsey, the FDA, and the Battle Against Thalidomide’ Review: The Noble Bureaucrat
The Wall Street Journal· 7 hours agoS. (Today the drug has been approved, with restrictions, to treat leprosy and multiple myeloma.) As...
FDA fast tracks Quince Therapeutics’ rare ataxia drug EryDex
Pharmaceutical Technology via Yahoo Finance· 12 hours agoThe status allows for earlier interactions with the FDA as Quince seeks accelerated approval, and...
Microbot’s LIBERTY robotic system secures FDA approval for pivotal trial
Medical Device Network via Yahoo Finance· 13 hours ago"Microbot’s LIBERTY robotic system secures FDA approval for pivotal trial" was originally created...
MDMA Treatment for PTSD Being Considered by FDA Advisers
TMZ· 26 minutes agoA pharmaceutical version of MDMA, also known as midomafetamine, could become a new treatment for...
FDA Warns Recalled Cookie Dough Company Over “Serious Violations”
IFLScience· 8 hours agoBack in October 2023, a Cookies-N-Milk product was issued a Class I recall – the most serious kind –...
Ecstasy as a PTSD treatment gets thumbs down from FDA advisers
Market Watch· 7 hours agoIn votes taken late Tuesday, the majority of the FDA advisory panel’s members said the available...